A company developing a novel wound care product was embarking on a significant clinical trial programme. Being hopeful of a positive outcome from the clinical trial programme, the client was planning an investor exit in the coming 24 months and therefore wanted to connect with potential acquirers prior to moving on to deal execution.
Alacrita conducted desk research to draw upon public domain information, Alacrita’s own databases and industry knowledge to identify potential target organisations on behalf of the client, with the intent of the client ultimately initiating a deal execution process. This was followed by identification of appropriate individuals within those organisations to engage with and canvass their interest in the client and its technology. Alacrita arranged initial meetings with senior level employees in the organisation in order to gain their detailed attention and influence key stakeholders. The campaign involved maintaining regular contact with the chosen target organisations in order to update them on progress with the client’s clinical trial programme, and also to gauge any changing interest in their appetite for an acquisition.
Alacrita also reviewed the wound management technology landscape on a quarterly basis to keep a watch on the progress of potentially competing products that might influence the outcome of an exit.Back